Monday, September 28, 2026

BTC $83,112 ▼ 0.42%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.246−0.40%ETH$2,675−0.46%LINK$15.36−0.51%SOL$118.06−0.65%BTC$83,112−0.42%XRP$1.49−0.52%S&P 5007,684−0.77%Nasdaq26,820−0.92%Dow51,482−0.67%RUT2,818−0.69%TNX5.24%+1.08%TYX5.56%+1.04%FVX5.07%+1.22%IRX4.06%−0.32%VIX16.07+8.07%GOLD$4,150.90−0.42%SILVER$60.96−1.24%OIL$93.30+0.76%DXY101.24+0.04%NVDA$228.86+1.68%AAPL$338.40−0.78%TSLA$357.45−3.94%META$715.62−4.79%MSFT$509.22−1.35%AMZN$246.15−1.41%GOOGL$342.75−0.34%Fear & Greed73 — GreedADA$0.246−0.40%ETH$2,675−0.46%LINK$15.36−0.51%SOL$118.06−0.65%BTC$83,112−0.42%XRP$1.49−0.52%S&P 5007,684−0.77%Nasdaq26,820−0.92%Dow51,482−0.67%RUT2,818−0.69%TNX5.24%+1.08%TYX5.56%+1.04%FVX5.07%+1.22%IRX4.06%−0.32%VIX16.07+8.07%GOLD$4,150.90−0.42%SILVER$60.96−1.24%OIL$93.30+0.76%DXY101.24+0.04%NVDA$228.86+1.68%AAPL$338.40−0.78%TSLA$357.45−3.94%META$715.62−4.79%MSFT$509.22−1.35%AMZN$246.15−1.41%GOOGL$342.75−0.34%Fear & Greed73 — Greed

Tag

oncology

2 articles

Research & Analysis40d ago

Merck, Moderna's mRNA Melanoma Vaccine Succeeds in Phase 3 Trial

Intismeran, combined with Keytruda, reduced melanoma recurrence—the first neoantigen vaccine to clear a late-stage randomized trial.

U.S. Equities42d ago

Jefferies Initiates Freenome With Buy, Sees 47% Upside in Cancer Screening

Jefferies set a $17 price target on Freenome (FRNM), trading at $11.56, citing the company's cancer screening potential as the core catalyst